Clinical trial Recruiting at 1 site Interventional Ages 60 to 85

Low-intensity transcranial ultrasound for sleep disturbances in people with chronic tinnitus

Official title: A Pilot Randomized Controlled Trial of MRI-guided Focused Low-intensity Transcranial Ultrasound Stimulation (TUS) for Sleep Disturbances in Patients With Chronic Tinnitus

Run by Chinese University of Hong Kong · NCT06776705 · Data updated 2026-11-12

This will test whether two weeks of focused low-intensity transcranial ultrasound to deep brain areas can reduce tinnitus severity and improve sleep in people aged 60–80 with chronic tinnitus and poor sleep.

More Cognition trials

Quick facts

Study typeInterventional
Ages60 Years to 85 Years
SexAll
Enrollment14 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations2 sites (Hong Kong, Hong Kong and 1 other locations)
StatusRecruiting
StartedJanuary 15, 2025
Main results expectedDecember 31, 2025
Study endsJune 30, 2026
Registry record updatedJuly 18, 2025
Trial IDNCT06776705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese, right-handed adults aged 60–80 who have had chronic tinnitus for at least three months and a PSQI score above 5, and who can attend in-person sessions at the study site.

Probably not a fit

Patients with active ear canal or tympanic membrane disease, Meniere's disease, acoustic neuroma, prior neurological or major psychiatric disorders, significant communicative impairments, or those already receiving regular tinnitus therapies are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an interventional feasibility study testing a 2-week course of focused low-intensity transcranial ultrasound stimulation (TUS) aimed at deep brain targets such as the hippocampus in older adults with chronic tinnitus and sleep disturbance. Primary outcomes are changes in tinnitus symptoms and sleep quality, with secondary outcomes including cognitive function and quality of life; analyses will use intention-to-treat and mixed-effects models. The protocol will also document tolerability, adherence, and adverse events to establish safety and to inform sample size for a future full-scale randomized trial. Participants are Chinese, right-handed adults aged 60–80 with chronic tinnitus (≥3 months) and a PSQI score >5, recruited at Tai Po Hospital in Hong Kong.

Why it matters

Potential benefit: If successful, the approach could provide a non-drug option to reduce tinnitus burden and improve sleep and related cognitive outcomes in older adults.

How similar studies have gone: Focused low-intensity transcranial ultrasound is an emerging technique with some early preclinical and small human safety signals, but there is limited published evidence specifically supporting benefit for tinnitus-related sleep problems.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chinese, right-handed, aged from 60 to 80 years.
* Chronic tinnitus is defined as tinnitus with a duration of at least 3 months. Depending on the justification, different time course definitions of chronic tinnitus are possible.
* Sleep disturbances are defined as a Pittsburgh Sleep Quality Index (PSQI) total score above 5.
* No interference with independence in everyday activities.

Exclusion Criteria:

* Diseases of ear canal and tympanic membrane checked by otoscopic examination.
* Previous diagnosis of Meniere's disease and acoustic neuromas.
* Past history of neurological or mental disorders.
* Physically frail affecting attendance to treatment sessions.
* Already attending regular treatments, such as cognitive behavioral therapy or music therapy.
* Taking a psychotropic or other medication known to affect hearing functions.
* Significant communicative impairments.

Where it's running

  • Tai Po Hospital
    Hong Kong, Tai Po District, Hong Kong
    Recruiting
  • Tai Po Hospital
    Hong Kong, Hong Kong, Hong Kong
    Not yet recruiting

Study contacts

  • Principal investigator: Hanna LU, PhD — Chinese University of Hong Kong
  • Study coordinator: Xi Ni, PhD
  • Email: xini@cuhk.edu.hk
  • Phone: 852-28314305

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.